Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
A 27-protein signature has been proposed to predict cardiovascular disease, but its applicability in clinical decision-making remains unclear.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/scitranslmed.abq4810 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Heart Failure Prediction in Dysglycemia: Are We Ready to Trust the Proteome?
Eur J Prev Cardiol
September 2025
Cardiovascular Disease Prevention Center, Massachusetts General Hospital, Boston, MA 02114.
Probing the Proteome for Atrial Fibrillation.
Circulation
July 2025
TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
A Peek into Pulmonary Hypertension through the Plasma Proteome.
Am J Respir Crit Care Med
August 2025
Department of Medicine Indiana University Indianapolis, Indiana.
The case for including proteomics in routine diagnostic practice for rare disease.
Genome Med
May 2025
Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, USA.
Many people with rare diseases cannot access personalized therapies because they do not have a confirmed genetic diagnosis. Promising technologies including proteomics are underutilized in routine diagnostic practice. It is time to incorporate proteomics into the diagnostic workflow to shorten time to diagnosis and expand treatment options for rare disease.
View Article and Find Full Text PDFToward Proteomic Precision Medicine for Steatotic Liver Diseases.
J Am Heart Assoc
May 2025
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care University Hospital RWTH Aachen Aachen Germany.